BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

Clinical trial NCT06608940 · WITHDRAWN

Trial details

NCT number: NCT06608940
Sponsor: Case Comprehensive Cancer Center
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)

Start date: 2025-11-01
Primary completion: 2027-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.